Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Crusia 4000IU


Not recommended
As a precautionary measure

May be acceptable
Crusia 4000IU :
Type Medicine Authorised
Originator Lovenox 4000IU
Agent Hikma-Liban
Distributor Hikma-Liban
Laboratory Rovi
Responsible Party Laboratorios Farmaceuticos Rovi SA
Origin Spain
Manufacturer Rovi Contract Manufacturing S.L.C.
Manufacturing Type G
Origin Spain
ATC B01AB05

Your comment will appear shortly after approval

Crusia 4000IU :

Revision Date : 30/12/2015


Effect Frequency
Allergic reaction Common
Alopecia Not known
Anaphylactic reactions Rare
Anaphylactic shock Not known
Anaphylactoid reactions Rare
Cephalea Not known
Cholestatic liver injury Not known
Dermatitis bullous Uncommon
Ecchymosis Very Common
Epistaxis (Nasal bleeding) Very Common
Erythema Common
Gastrointestinal bleeding Very Common
Haematoma Very Common
Haematuria (Hematuria) Very Common
Haemorrhage Very Common
Haemorrhage intracranial Uncommon
Haemorrhagic anaemia Not known
Heparin-induced thrombocytopenia Not known
Hepatic enzyme increased Very Common
Hepatocellular injury Not known
Hypereosinophilia Not known
Hyperkalaemia Rare
Injection site allergic reaction Common
Injection site haematoma Common
Injection site haemorrhage Common
Injection site inflammation Common
Injection site irritation Uncommon
Injection site necrosis Uncommon
Injection site nodule Common
Injection site oedema Common
Injection site pain Common
Intraspinal haematoma Not known
Osteoporosis Not known
Platelet count increased Not known
Post procedural haematoma Very Common
Pruritus Common
Retroperitoneal haemorrhage Rare
Serum transaminase increased Very Common
Skin necrosis Not known
Thrombocytopenia (Thrombopenia) Common
Thrombocytosis Very Common
Urticaria Common
Vasculitides Not known

Different Units By MoH Code

Crusia 4000IU  MoH 10385 :
Form Solution for injection
Packaging Pre-filled Syringe
Package Size 10x0.4ml
Strength 40mg = 4000IU Anti-Xa/0.4ml
Public Price 2053592.92 L.L.
Stratum B
NSSF ✘
Quarantine ✘
Reg. Number 145119/1
Submission date 03/10/2019
Registration Year 03/10/2019
Pending Year 18/06/2020


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 10x0.4ml
● Public Price: 2053592.92 LBP ( 2,053,592.92 LBP )
● Pack size unit used: 40000
● Cost/Unit: 51,34 LBP ( 51.00 LBP )
● Pricing Date: 13/06/2024

● Country: France
● Package Size: 6x0.4ml
● Public Price: 25.7 EUR ( 2,489,713.20 LBP )
● Pack size unit used: 24000
● Cost/Unit: 0,0011 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 10
● Public Price: 22.7 GBP ( 2,579,832.30 LBP )
● Pack size unit used: 40000
● Cost/Unit: 0,0006 GBP ( 0.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 10x0.4ml
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 14/10/2019
● Type: Medicine Authorised

● Country: Finland
● Package Size: 10x0.4ml
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info